Curcumin-phosphatidylcholine complex (CPC)

Curcumin-phosphatidylcholine micelle, often referred to as a curcumin phytosome, is a specialized drug delivery system designed to enhance the bioavailability of curcumin, a polyphenol derived from turmeric (Curcuma longa) (Cuomo et al., 2011). Curcumin is known for its potent anti-inflammatory, antioxidant, and anti-carcinogenic properties, but its clinical efficacy is severely limited by poor aqueous solubility, rapid metabolism, and low intestinal absorption (Anand et al., 2007). By complexing curcumin with phosphatidylcholine, the formulation creates a lipid-compatible micellar structure that facilitates the transport of curcumin across the lipid bilayer of the gastrointestinal mucosa (Kidd, 2009). This delivery technology, exemplified by the brand Meriva, has been shown in clinical studies to increase the absorption of curcuminoids by nearly 30-fold compared to unformulated extracts (Belcaro et al., 2010). While the complex itself is not a biological target, it serves as a vehicle to deliver curcumin to its intracellular targets, such as the transcription factor NF-κB and enzymes like COX-2. Consequently, it is primarily used in the management of chronic inflammatory conditions, including osteoarthritis and metabolic syndrome (Daily et al., 2016). The use of this formulation allows for lower dosing while achieving therapeutic systemic concentrations of curcumin.

Other names

MerivaCurcumin phytosomeCurcumin-PCCurcumin-phospholipid complexCurcumin-phosphatidylcholine micelle

The formulation acts as a delivery vehicle that improves the solubility and membrane permeability of curcumin by forming a phytosome complex, which mimics the lipid environment of cell membranes to facilitate passive diffusion across the intestinal epithelium (Cuomo et al., 2011).